Detailed information for compound 175162

Basic information

Technical information
  • TDR Targets ID: 175162
  • Name: 2-[5-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl) piperidin-1-yl]methyl]pyrrolidin-1-yl]sulfony lthiophen-2-yl]pyridine
  • MW: 585.822 | Formula: C34H39N3O2S2
  • H donors: 0 H acceptors: 3 LogP: 7.31 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=S(=O)(c1ccc(s1)c1ccccn1)N1C[C@@H]([C@H](C1)c1ccccc1)CN1CCC(CC1)CCCc1ccccc1
  • InChi: 1S/C34H39N3O2S2/c38-41(39,34-18-17-33(40-34)32-16-7-8-21-35-32)37-25-30(31(26-37)29-14-5-2-6-15-29)24-36-22-19-28(20-23-36)13-9-12-27-10-3-1-4-11-27/h1-8,10-11,14-18,21,28,30-31H,9,12-13,19-20,22-26H2/t30-,31+/m0/s1
  • InChiKey: IMKUHYXVQQEXJP-IOWSJCHKSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[5-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)-1-piperidyl]methyl]pyrrolidin-1-yl]sulfonyl-2-thienyl]pyridine
  • 2-[5-[[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)-1-piperidinyl]methyl]-1-pyrrolidinyl]sulfonyl]-2-thienyl]pyridine
  • 2-[5-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)piperidino]methyl]pyrrolidino]sulfonyl-2-thienyl]pyridine
  • AIDS-112324
  • AIDS112324
  • Pyridine, 2-[5-[[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)-1-piperidinyl]methyl]-1-pyrrolidinyl]sulfonyl]-2-thienyl]-

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens chemokine (C-C motif) receptor 2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.0465 0.1384 0.5
Echinococcus multilocularis ring and YY1 binding protein 0.0465 0.1384 0.1384
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.1306 1 1
Leishmania major hypothetical protein, conserved 0.0465 0.1384 0.5
Schistosoma mansoni hypothetical protein 0.1306 1 1
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.0465 0.1384 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0465 0.1384 0.5
Echinococcus granulosus zinc finger protein Ran binding 0.0465 0.1384 0.1384
Trypanosoma brucei mitochondrial RNA binding complex 1 subunit 0.0465 0.1384 0.5
Echinococcus multilocularis zinc finger protein Ran binding 0.0465 0.1384 0.1384
Trypanosoma cruzi hypothetical protein, conserved 0.0465 0.1384 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.1306 1 1
Leishmania major hypothetical protein, conserved 0.0465 0.1384 0.5
Trypanosoma brucei Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.0465 0.1384 0.5
Echinococcus granulosus Nuclear pore complex protein Nup153 0.0465 0.1384 0.1384
Loa Loa (eye worm) brahma associated protein 0.1306 1 1
Schistosoma mansoni hypothetical protein 0.1306 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.1306 1 1
Echinococcus multilocularis Nuclear pore complex protein Nup153 0.0465 0.1384 0.1384
Trypanosoma brucei hypothetical protein, conserved 0.0465 0.1384 0.5
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.0465 0.1384 0.5
Leishmania major hypothetical protein, conserved 0.0465 0.1384 0.5
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.1306 1 1
Leishmania major hypothetical protein, conserved 0.0465 0.1384 0.5
Trypanosoma brucei hypothetical protein, conserved 0.0465 0.1384 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.1306 1 1
Trypanosoma cruzi WLM domain containing protein, putative 0.0465 0.1384 0.5
Trypanosoma cruzi Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.0465 0.1384 0.5
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.1306 1 1
Echinococcus granulosus ring and YY1 binding protein 0.0465 0.1384 0.1384
Brugia malayi SWIB/MDM2 domain containing protein 0.1306 1 1
Leishmania major hypothetical protein, conserved 0.0465 0.1384 0.5
Plasmodium vivax hypothetical protein, conserved 0.1306 1 0.5
Schistosoma mansoni brg-1 associated factor 0.1306 1 1
Echinococcus granulosus Zinc finger RanBP2 type 0.0465 0.1384 0.1384
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.1306 1 1
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.0465 0.1384 0.5
Trypanosoma cruzi WLM domain containing protein, putative 0.0465 0.1384 0.5
Echinococcus granulosus Upstream activation factor subunit UAF30 0.1306 1 1
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.1306 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0465 0.1384 0.5
Chlamydia trachomatis SWIB complex protein 0.1306 1 0.5
Echinococcus granulosus SWI:SNF matrix associated 0.1306 1 1
Schistosoma mansoni hypothetical protein 0.1306 1 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.1306 1 1
Echinococcus multilocularis Zinc finger, RanBP2 type 0.0465 0.1384 0.1384
Brugia malayi brahma associated protein 60 kDa 0.1306 1 1
Chlamydia trachomatis DNA topoisomerase I 0.1306 1 0.5
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.1306 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.1306 1 0.5
Onchocerca volvulus 0.1306 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 60 nM Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes ChEMBL. 11720860
IC50 (binding) = 60 nM Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes ChEMBL. 11720860

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.